{
    "accession": "ENCBS260TRO", 
    "age": "50", 
    "age_units": "year", 
    "applied_modifications": [], 
    "biosample_term_id": "EFO:0002071", 
    "biosample_term_name": "LNCAP", 
    "biosample_type": "immortalized cell line", 
    "characterizations": [], 
    "dbxrefs": [], 
    "description": "", 
    "documents": [
        {
            "attachment": "/documents/61c208ad-bbc6-4111-8f98-720408404263/@@download/attachment/LNCaP_DHT_Treatment_Cell_Culture_Farnham_150720.pdf", 
            "document_type": "growth protocol", 
            "references": [], 
            "urls": []
        }
    ], 
    "donor": "ENCDO000ACX", 
    "health_status": "prostate adenocarcinoma", 
    "lab": "Michael Snyder, Stanford", 
    "life_stage": "adult", 
    "organism": "Homo sapiens", 
    "references": [], 
    "sex": "male", 
    "source": "ATCC", 
    "summary": "Homo sapiens LNCAP immortalized cell line treated with 10 nM 17\u03b2-hydroxy-5\u03b1-androstan-3-one for 4 hours", 
    "treatments": [
        {
            "dbxrefs": [], 
            "duration": 4, 
            "duration_units": "hour", 
            "treatment_term_id": "CHEBI:16330", 
            "treatment_term_name": "17\u03b2-hydroxy-5\u03b1-androstan-3-one", 
            "treatment_type": "chemical"
        }
    ]
}